Gilenya: new MS drug approved by Health CanadaHealth Canada approves first disease-modifying oral treatment for multiple sclerosis in Canada. Brain scans reveal secrets of acupuncture’s successTechnique blocks pain signals and reduces expectations of pain, MRI shows MRS detects athletes’ concussion damage Researcher hopes technique allows for ‘in-life diagnosis’ Should patients with ‘mild’ strokes get tPA? Few receive the clot buster, despite substantial risk of disability Radiation prevents brain metastases without memory loss But doctors are reluctant to allow their patients to take part in preventive studies Walking protects the brain Keeping active slows the progression of cognitive impairment, study shows MDs work to connect malformed veins to MS Doctors wrestle with how to care for patients who had controversial procedure abroad Stroke Prevention Educating patients and managing risk factors to prevent stroke. Copaxone co-packaged with recalled alcohol prep pads MS drug co-packaged in kit containing recalled alcohol prep pads. Arthritis biologics may cut Alzheimer’s risk First Previous 39 40 41 42 43 Next Last
